Menu
GeneBe

FPGS

folylpolyglutamate synthase

Basic information

Region (hg38): 9:127794596-127814327

Links

ENSG00000136877NCBI:2356OMIM:136510HGNC:3824Uniprot:Q05932AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FPGS gene.

  • Inborn genetic diseases (16 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FPGS gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
15
clinvar
1
clinvar
1
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 15 1 1

Variants in FPGS

This is a list of pathogenic ClinVar variants found in the FPGS region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-127802935-C-T not specified Uncertain significance (May 06, 2022)2386449
9-127802937-C-T not specified Uncertain significance (Jan 23, 2023)2466737
9-127802943-C-T not specified Uncertain significance (Feb 28, 2024)3096637
9-127802988-A-G Benign (Oct 29, 2020)1232138
9-127803001-T-G not specified Uncertain significance (Jul 14, 2021)2216771
9-127803012-C-T not specified Uncertain significance (Oct 27, 2022)2387790
9-127803013-G-A not specified Uncertain significance (Aug 17, 2021)2373825
9-127804295-G-A not specified Uncertain significance (Jun 21, 2023)2593860
9-127804349-A-C not specified Uncertain significance (Dec 09, 2023)3096638
9-127804382-T-C not specified Uncertain significance (Jan 30, 2024)3096639
9-127804655-C-T not specified Uncertain significance (Mar 03, 2022)2212026
9-127808301-A-G not specified Uncertain significance (Oct 13, 2023)3096640
9-127808825-G-C not specified Uncertain significance (Jan 17, 2024)2349029
9-127808836-T-C not specified Uncertain significance (Feb 06, 2024)3096635
9-127809781-G-C not specified Uncertain significance (Feb 13, 2023)2456699
9-127809806-G-A not specified Uncertain significance (Sep 09, 2021)2248900
9-127810066-C-T not specified Uncertain significance (Mar 16, 2023)2522171
9-127810966-G-A not specified Uncertain significance (May 27, 2022)2275049
9-127813323-G-A not specified Uncertain significance (Nov 01, 2022)2321751
9-127813332-G-A not specified Likely benign (Jul 12, 2022)2353755
9-127813347-G-A not specified Uncertain significance (Sep 06, 2022)2374951
9-127813467-G-A not specified Uncertain significance (Oct 27, 2023)3096636
9-127813500-G-C not specified Uncertain significance (Oct 12, 2022)2318104

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FPGSprotein_codingprotein_codingENST00000373247 1519731
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000001160.9981257180301257480.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.892393370.7100.00002073684
Missense in Polyphen4390.3640.47585989
Synonymous0.6241411510.9350.000009481247
Loss of Function2.681531.10.4820.00000164322

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001580.000152
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00009680.0000924
European (Non-Finnish)0.0001530.000149
Middle Eastern0.0001630.000163
South Asian0.00009800.0000980
Other0.0003480.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. Unsubstituted reduced folates are the preferred substrates. Metabolizes methotrexate (MTX) to polyglutamates. {ECO:0000269|PubMed:8408018, ECO:0000269|PubMed:8408019, ECO:0000269|PubMed:8408021, ECO:0000269|PubMed:8662720}.;
Pathway
Fluoropyrimidine Pathway, Pharmacodynamics;Folate biosynthesis - Homo sapiens (human);Methotrexate Pathway (Cancer Cell), Pharmacodynamics;Folate malabsorption, hereditary;Methylenetetrahydrofolate Reductase Deficiency (MTHFRD);Methotrexate Action Pathway;Folate Metabolism;Fluoropyrimidine Activity;folate polyglutamylation;Folate metabolism;Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B9 (folate) metabolism (Consensus)

Recessive Scores

pRec
0.270

Intolerance Scores

loftool
0.742
rvis_EVS
-0.53
rvis_percentile_EVS
20.7

Haploinsufficiency Scores

pHI
0.0868
hipred
Y
hipred_score
0.515
ghis
0.484

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.865

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fpgs
Phenotype
growth/size/body region phenotype;

Gene ontology

Biological process
liver development;nucleobase-containing compound metabolic process;glutamate metabolic process;one-carbon metabolic process;folic acid-containing compound metabolic process;brain development;animal organ regeneration;folic acid metabolic process;tetrahydrofolylpolyglutamate biosynthetic process
Cellular component
cytoplasm;mitochondrion;mitochondrial inner membrane;mitochondrial matrix;cytosol
Molecular function
tetrahydrofolylpolyglutamate synthase activity;ATP binding;metal ion binding